S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|CTI BioPharma Announces Presentation of Data Demonstrating Pacritinib Overrides Stromal Mediated Resistance in FLT3-ITD Positive AML Cells|
|Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2015|
|Exelixis’ Collaborator Genentech Files New Drug Application for the Combination of Cobimetinib and Vemurafenib for the Treatment of Patients With BRAF V600 Mutation-Positive Advanced Melanoma|
|Clovis Oncology Enters into Oncology Clinical Trial Collaboration with GlaxoSmithKline|
|Array To Regain Worldwide Rights To Binimetinib (2014/12/3)|
|Exelixis Announces Positive Preliminary Data From an Investigator-Sponsored Phase 1 Trial of XL888 and Vemurafenib|
|Foundation Medicine and Collaborators to Present New Clinical Data on FoundationOne® Heme at the American Society of Hematology Annual Meeting|
|Exelixis Completes Enrollment of the METEOR Phase 3 Pivotal Trial of Cabozantinib in Metastatic Renal Cell Carcinoma|
|Exelixis Announces Positive Top-Line Results From a Phase 2 Trial of Cabozantinib and Erlotinib in Patients With EGFR Wild-Type Non-Small Cell Lung Cancer|
|Exelixis Announces Third Quarter 2014 Financial Results and Provides Corporate Update|
Click above to view more mutual fund data and stats for mek - Metals Creek Resources Corp.